The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Open accessAbstract
Detection of circulating tumor DNA in patients with resected stage II colon cancer provides evidence of residual disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a growing body of data demonstrating numerous clinical applications for ctDNA in adults with solid tumors, ranging from prognostication and evaluation of minimal residual disease (MRD) to detection of targetable alterations.7–12”
From Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN Study (2026) · cites this paper as [10]
In the citing paper
“A salient example of the well-established relationship between ctDNA burden and disease status in adult solid tumors is the use of ctDNA for MRD detection and monitoring for recurrence in colorectal cancers.10–12”
From Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN Study (2026) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Self-citationTime‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
Heagerty, P. J., Lumley, T., & PEPE, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,870
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Self-citationCirculating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K. E., Goodman, S. N., Li, M., Thornton, K. A., Agrawal, N., Sokoll, L. J., Szabo, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,746
Self-citationRibic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Misale, S., Yaeger, R., Hobor, S., Scala, E., Janakiraman, M., Liska, D., Valtorta, E., Schiavo, R., Buscarino, M., Siravegna, G., et al. (2012) · Nature · doi:10.1038/nature11156 · Cited by 1,889
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
Self-citationSargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623
Research works printed but not linked: 1
- S. Edge D. R. Byrd C. C. Compton A. G. Fritz F. L. Greene A. Trotti AJCC Cancer Staging Manual (Springer New York 2010) 648 pp.
Cited by
Sorted by citations
Items 301–400 of 1,001
Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer
Gallo, M., Luca, A. D., Maiello, M. R., D’Alessio, A., Esposito, C., Chicchinelli, N., Forgione, L., Piccirillo, M. C., Rocco, G., Morabito, A., et al. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.05.07 · Cited by 57
Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer
Nordgård, O., Tjensvoll, K., Gilje, B., & Søreide, K. (2018) · British journal of surgery · doi:10.1002/bjs.10782 · Cited by 57
Myint, N. N. M., Verma, A. M., Fernández-García, D., Sarmah, P. B., Tarpey, P. S., Al-Aqbi, S. S., Cai, H., Trigg, R. M., West, K., Howells, L. M., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0934-x · Cited by 57
Circulating Tumor DNA: An Emerging Tool in Gastrointestinal Cancers
Alese, O. B., Cook, N., Franco, A. O., Ulanja, M. B., Tan, L., & Tie, J. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_349143 · Cited by 54
Self-citationDuffy, M. J., & Crown, J. P. (2022) · Clinical Chemistry · doi:10.1093/clinchem/hvac121 · Cited by 55
Nakamura, Y., Tsukada, Y., Matsuhashi, N., Murano, T., Shiozawa, M., Takahashi, Y., Oki, E., Goto, M., Kagawa, Y., Kanazawa, A., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1651 · Cited by 59
Cottrell, T. R., Lotze, M. T., Ali, A. M., Bifulco, C. B., Capitini, C. M., Chow, L. Q. M., Cillo, A. R., Collyar, D. E., Cope, L., Deutsch, J. S., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010928 · Cited by 65
Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients
Christensen, E., Nordentoft, I., Vang, S., Birkenkamp-Demtröder, K., Jensen, J. B., Agerbæk, M., Pedersen, J. S., & Dyrskjøt, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-20282-8 · Cited by 56
A population genetics perspective on the determinants of intra-tumor heterogeneity
Hu, Z., Sun, R., & Curtis, C. N. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.03.001 · Cited by 54
New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis
Felsenstein, M., Hruban, R. H., & Wood, L. D. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000172 · Cited by 59
Cell-free DNA in cancer: current insights
Fettke, H., Kwan, E. M., & Azad, A. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0413-5 · Cited by 53
Liquid Biopsy Applications in the Clinic
Chen, D., Xu, T., Wang, S., Chang, H., Yu, T., Zhu, Y., & Chen, J. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00444-8 · Cited by 56
Circulating tumor DNA analysis in the era of precision oncology
Said, R., Guibert, N. M., Oxnard, G. R., & Tsimberidou, A. M. (2020) · Oncotarget · doi:10.18632/oncotarget.27418 · Cited by 53
Jacob, S. L., Davis, A. A., Gerratana, L., Velimirovic, M., Shah, A. N., Wehbe, F., Katam, N., Zhang, Q., Flaum, L., Siziopikou, K. P., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1566 · Cited by 56
In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer
Wei, R., Wong, J. P. C., Lyu, P., Xi, X., Tong, O., Zhang, S., Yuen, H. F., Shirasawa, S., & Kwok, H. F. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13686 · Cited by 52
Zou, W., Yaung, S. J., Fuhlbrück, F., Ballinger, M. D., Peters, E. J., Palma, J. F., Shames, D. S., Gandara, D. R., Jiang, Y., & Patil, N. S. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00057 · Cited by 52
Naegele, S., Ruiz‐Torres, D. A., Zhao, Y., Goss, D., & Faden, D. L. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2023.11.007 · Cited by 53
Hovelson, D. H., Liu, C., Wang, Y., Kang, Q., Henderson, J., Gursky, A. M., Brockman, S., Ramnath, N., Krauss, J. C., Talpaz, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21163 · Cited by 52
Self-citationCirculating tumor cells in clinical research and monitoring patients with colorectal cancer
Burz, C. C., Pop, V.-V., Buiga, R., Sur, D. G., Samaşcă, G., Aldea, C. O., & Lupan, I. (2018) · Oncotarget · doi:10.18632/oncotarget.25337 · Cited by 53
Kim, T. W., Peeters, M., Thomas, A., Gibbs, P., Hool, K., Zhang, J., Ang, A. L., Bach, B. A., & Price, T. J. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3377 · Cited by 52
Self-citationKato, S., Schwaederlé, M. C., Fanta, P. T., Okamura, R., Leichman, L., Lippman, S. M., Lanman, R. B., Raymond, V. M., Talasaz, A., & Kurzrock, R. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00158 · Cited by 52
Insights on CTC Biology and Clinical Impact Emerging from Advances in Capture Technology
Bailey, P. C., & Martin, S. S. (2019) · Cells · doi:10.3390/cells8060553 · Cited by 53
Genetic profiling of cancer with circulating tumor DNA analysis
Lu, L., Bi, J., & Bao, L. (2018) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2017.11.006 · Cited by 55
Pastor, B., Abraham, J.-D., Pisareva, E., Sánchez, C., Kudriavstev, A., Tanos, R., Mirandola, A., Mihalovičová, L., Pezzella, V., Adenis, A., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103826 · Cited by 52
Ros, J., Baraibar, I., Gonzalez, N. S., Rodríguez-Castells, M., Salvà, F., Tabernero, J. M., & Élez, E. (2023) · Cancers · doi:10.3390/cancers15174245 · Cited by 53
Kotrová, M., Trka, J., Kneba, M., & Brüggemann, M. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0277-9 · Cited by 50
Mutation Profiling of Malignant Lymphoma by Next-Generation Sequencing of Circulating Cell-Free DNA
Sun, P., Chen, C., Xia, Y., Wang, Y., Liu, P., Bi, X.-W., Shao, Y. W., Ou, Q.-X., Wu, X., Yang, H., et al. (2019) · Journal of Cancer · doi:10.7150/jca.27615 · Cited by 50
Self-citationCurrent and Emerging Biomarkers in Metastatic Colorectal Cancer
Lee, M. K. C., & Loree, J. M. (2019) · Current Oncology · doi:10.3747/co.26.5719 · Cited by 50
Nors, J., Henriksen, T. V., Gotschalck, K. A., Juul, T., Søgaard, J., Iversen, L. H., & Andersen, C. L. (2020) · Acta Oncologica · doi:10.1080/0284186x.2019.1711170 · Cited by 49
Pellini, B., Pejovic, N., Feng, W., Earland, N. J., Harris, P. K. W., Usmani, A., Szymanski, J. J., Qaium, F., Mudd, J. L., Petty, M., et al. (2021) · JCO Precision Oncology · doi:10.1200/po.20.00276 · Cited by 52
Germano, G., Mauri, G., Siravegna, G., Dive, C., Pierce, J., Nicolantonio, F. D., D’Incalci, M., Bardelli, A., Siena, S., & Bianchi, A. S. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.10.017 · Cited by 49
Circulating epigenetic biomarkers for detection of recurrent colorectal cancer
Symonds, E. L., Pedersen, S. K., Murray, D. H., Byrne, S. E., Roy, A. C., Karapetis, C. S., Hollington, P., Rabbitt, P., Jones, F. S., LaPointe, L. C., et al. (2020) · Cancer · doi:10.1002/cncr.32695 · Cited by 49
The Role of Cell-Free DNA in Cancer Treatment Decision Making
Telekes, A., & Horváth, A. (2022) · Cancers · doi:10.3390/cancers14246115 · Cited by 50
Berger, A. W., Schwerdel, D., Welz, H., Marienfeld, R. B., Schmidt, S. A., Kleger, A., Ettrich, T. J., & Seufferlein, T. T. W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174308 · Cited by 48
Fadda, A., Gentilini, D., Moi, L., Barault, L., Leoni, V. P., Sulas, P., Zorcolo, L., Restivo, A., Cabras, F., Fortunato, F., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31380 · Cited by 48
Qin, Y., Wu, L. J., Schneider, T., Yen, G. S., Wang, J., Xu, S., Li, M., Paguirigan, A. L., Smith, J. L., Radich, J. P., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807314 · Cited by 48
Papadopoulos, N. (2019) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-26439-0_9 · Cited by 49
Self-citationTargeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver
Ros, J., Vaghi, C., Baraibar, I., Gonzalez, N. S., Rodríguez-Castells, M., García, A., Alcaráz, A., Salvà, F., Tabernero, J. M., & Élez, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063304 · Cited by 53
Precision medicine for gastrointestinal cancer: Recent progress and future perspective
Matsuoka, T., & Yashiro, M. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i1.1 · Cited by 46
Kasi, P. M., Sawyer, S. D., Guilford, J., Munro, M., Ellers, S., Wulff, J. E., Hook, N., Krinshpun, S., Malashevich, A. K., Malhotra, M., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047831 · Cited by 47
Hermunen, K. M., Soveri, L., Boisen, M. K., Mustonen, H. K., Dehlendorff, C., Haglund, C. H., Johansen, J. S., & Osterlund, P. J. (2020) · Acta Oncologica · doi:10.1080/0284186x.2020.1800086 · Cited by 46
Ferrier, S. T., Tsering, T., Sadeghi, N., Zeitouni, A. G., & Burnier, J. V. (2023) · Cancer Medicine · doi:10.1002/cam4.6191 · Cited by 46
Circulating tumor cells: silent predictors of metastasis
Zhou, L., Dicker, D. T., Matthew, E. M., El‐Deiry, W. S., & Alpaugh, R. K. (2017) · F1000Research · doi:10.12688/f1000research.11313.1 · Cited by 46
Extending Circulating Tumor DNA Analysis to Ultralow Abundance Mutations: Techniques and Challenges
Rodda, A. E., Parker, B. J., Spencer, A. G., & Corrie, S. R. (2018) · ACS Sensors · doi:10.1021/acssensors.7b00953 · Cited by 46
RAS genes in colorectal carcinoma: pathogenesis, testing guidelines and treatment implications
Saeed, O. A. M., Antonio Lopez-beltran, B., Fisher, K. W., Scarpelli, M., Montironi, R., Cimadamore, A., Massari, F., Santoni, M., & Liang Cheng, C. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205471 · Cited by 47
Liquid biopsy for rectal cancer: A systematic review
Massihnia, D., Pizzutilo, E. G., Amatu, A., Tosi, F., Ghezzi, S., Bencardino, K. B., Masi, P. D., Righetti, E., Patelli, G., Scaglione, F., et al. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.101893 · Cited by 46
The diagnostic and prognostic usage of circulating tumor DNA in operable hepatocellular carcinoma.
An, Y., Guan, Y., Xu, Y., Han, Y., Wu, C., Bao, C., Zhou, B., Wang, H., Zhang, M., Liu, W., et al. (2019) · Europe PMC (PubMed Central) · Cited by 48
Clinical Perspective and Translational Oncology of Liquid Biopsy
Fernández‐Lázaro, D., Garcı́a, J. L., Caballero-García, A., del Castillo, A. C., Hueso, M. V., & Cruz, J. J. (2020) · Diagnostics · doi:10.3390/diagnostics10070443 · Cited by 50
Bolhuis, K., Erve, I. V. ’., Mijnals, C., Diemen, P. M. D., Huiskens, J., Komurcu, A., López‐Yurda, M., van den Broek, D. A., Swijnenburg, R., Meijer, G. A., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103498 · Cited by 46
Liquid biopsies for residual disease and recurrence
Wan, J. C. M., Mughal, T. I., Razavi, P., Dawson, S., Moss, E. L., Govindan, R., Tan, I. B., Yap, Y. S., Robinson, W. A., Morris, C. D., et al. (2021) · Med · doi:10.1016/j.medj.2021.11.001 · Cited by 48
Self-citationCirculating tumor cells and circulating tumor DNA: What surgical oncologists need to know?
Cabel, L., Proudhon, C., Mariani, P., Tzanis, D., Beinse, G., Bièche, I., Pierga, J., & Bidard, F. (2017) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2017.01.010 · Cited by 46
Cell-Free DNA in Oncology: Gearing up for Clinic
Ulrich, B. C., & Paweletz, C. P. (2017) · Annals of Laboratory Medicine · doi:10.3343/alm.2018.38.1.1 · Cited by 47
Circulating tumour DNA, a promising biomarker for the management of colorectal cancer
Khakoo, S. S., Georgiou, A., Gerlinger, M., Cunningham, D., & Starling, N. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.12.002 · Cited by 47
Circulating Tumor DNA for Early Cancer Detection
Fiala, C., Kulasingam, V., & Diamandis, E. P. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.026393 · Cited by 45
Vivancos, A. P., Aranda, E., Benavides, M., Élez, E., Gómez‐España, M. A., Toledano‐Fonseca, M., Álvarez, M., Chica-Parrado, M. D. R., García‐Barberán, V., & Díaz‐Rubio, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-45616-y · Cited by 47
Chibuk, J., Flory, A., Kruglyak, K. M., Leibman, N. F., Nahama, A., Dharajiya, N. G., van den Boom, D., Jensen, T. J., Friedman, J. S., Shen, M. R., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.664718 · Cited by 45
Self-citationKuang, P., Li, N., Liu, Z., Sun, T., Wang, S.-Q., Hu, J., Ou, W., & Wang, S.-Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.595650 · Cited by 44
Bronkhorst, A. J., & Holdenrieder, S. (2023) · Medizinische Genetik · doi:10.1515/medgen-2023-2065 · Cited by 48
Roidos, P., Sungalee, S., Benfatto, S., Serçin, Ö., Stütz, A. M., Abdollahi, A., Mauer, J., Zenke, F. T., Korbel, J. O., & Mardin, B. R. (2020) · Nature Communications · doi:10.1038/s41467-020-17962-3 · Cited by 43
Multiplex detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS assay
Lyu, N., Rajendran, V. K., Diefenbach, R. J., Charles, K. A., Clarke, S. J., Engel, A. F., Sydney 1000 Colorectal Cancer Study Investigators*, Rizos, H., Molloy, M. P., & Wang, Y. (2020) · Nanotheranostics · doi:10.7150/ntno.48905 · Cited by 44
Self-citationMaaß, K. K., Schad, P. S., Finster, A. M. E., Puranachot, P., Rosing, F., Wedig, T., Schwarz, N., Stumpf, N., Pfister, S. M., & Pajtler, K. W. (2021) · Cancers · doi:10.3390/cancers13123002 · Cited by 44
Iwaya, T., Endo, F., Yaegashi, M., Sasaki, N., Fujisawa, R., Hiraki, H., Akiyama, Y., Sasaki, A., Suzuki, Y., Masuda, M., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.09.035 · Cited by 43
Boukouris, A. E., Michaelidou, K., Joosse, S. A., Charpidou, A. G., Mavroudis, D., Syrigos, K. N., & Agelaki, S. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00984-9 · Cited by 46
Liquid biopsies across the cancer care continuum
Landon, B. V., Annapragada, A. V., Niknafs, N., Velculescu, V. E., & Anagnostou, V. (2025) · Nature Medicine · doi:10.1038/s41591-025-04093-9 · Cited by 55
Brown, N. A., Aisner, D. L., & Oxnard, G. R. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_209089 · Cited by 45
Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer
Egyud, M., Sridhar, P., Devaiah, A. K., Yamada, E., Saunders, S. S., Ståhlberg, A., Filges, S., Krzyzanowski, P. M., Kalatskaya, I., Jiao, W., et al. (2018) · Head & Neck · doi:10.1002/hed.25563 · Cited by 43
The current status of the clinical utility of liquid biopsies in cancer
Snow, A. E., Chen, D., & Lang, J. E. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1664290 · Cited by 44
Yaung, S. J., Fuhlbrück, F., Peterson, M., Zou, W., Palma, J. F., Patil, N. S., & Jiang, Y. (2020) · JCO Precision Oncology · doi:10.1200/po.20.00046 · Cited by 48
The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication
Labgaa, I., Villanueva, A., Dormond, O., Demartines, N., & Melloul, E. (2021) · Cancers · doi:10.3390/cancers13040659 · Cited by 46
Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomas
Braig, D., Becherer, C., Bickert, C., Braig, M., Claus, R., Eisenhardt, A. E., Heinz, J., Scholber, J., Herget, G. W., Bronsert, P., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32216 · Cited by 42
The Promise of Circulating Tumor DNA in Head and Neck Cancer
Aulakh, S. S., Silverman, D. A., Young, K., Dennis, S. K., & Birkeland, A. C. (2022) · Cancers · doi:10.3390/cancers14122968 · Cited by 44
Hirotsu, Y., Yokoyama, H., Amemiya, K., Hagimoto, T., Daimon, H., Hosaka, K., Oyama, T., Mochizuki, H., & Omata, M. (2019) · Cancer Science · doi:10.1111/cas.14155 · Cited by 43
Bender, U., Rho, Y. S., Barrera, I., Aghajanyan, S., Acoba, J., & Kavan, P. (2019) · Current Oncology · doi:10.3747/co.26.5605 · Cited by 36
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer
Zhou, Q. X., Perakis, S. O., Ulz, P., Mohan, S., Riedl, J. M., Talakić, E., Lax, S., Tötsch, M., Höefler, G., Bauernhofer, T., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-0719-6 · Cited by 43
McDannold, N. J., Zhang, Y., Supko, J. G., Power, C., Sun, T., Vykhodtseva, N. I., Golby, A. J., & Reardon, D. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-65617-6 · Cited by 42
Andersson, D., Kristiansson, H., Kubista, M., & Ståhlberg, A. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1889371 · Cited by 42
Lin, P., Wang, M., Lo, C., Tsai, L., Yen, T., Huang, T. Y., Huang, W., Yang, K., Chen, C., Fan, S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.736769 · Cited by 42
Newhook, T. E., Overman, M. J., Chun, Y. S., Dasari, A. N., Tzeng, C.-W. D., Cao, H. S. T., Raymond, V. M., Parseghian, C. M., Johnson, B., Nishioka, Y., et al. (2022) · Annals of Surgery · doi:10.1097/sla.0000000000005461 · Cited by 43
Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer
Carrasco, R., Ingelmo‐Torres, M., Gómez, A., Trullás, R., Roldán, F. L., Ajami, T., Moreno, D., Rodríguez‐Carunchio, L., Alcaraz, A., Izquierdo, L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911732 · Cited by 42
Yuan, S., Nie, R., Huang, Y., Chen, Y., Wang, S., Sun, X., Li, Y., Liu, Z., Chen, Y., Yao, Y.-C., et al. (2023) · 癌症：英文版 · doi:10.1002/cac2.12494 · Cited by 39
Whilde, J., Martindale, M. Q., & Duffy, D. J. (2016) · Global Change Biology · doi:10.1111/gcb.13548 · Cited by 39
Taı̈eb, J., Benhaïm, L., Laurent‐Puig, P., Malicot, K. L., Emile, J., Geillon, F., Tougeron, D., Manfrédi, S., Chauvenet, M., Taly, V., et al. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.04.010 · Cited by 41
Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy
Liu, S., & Wang, J. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44060184 · Cited by 41
Chen, H., & Zhou, Q. (2023) · Oncology Reports · doi:10.3892/or.2023.8543 · Cited by 44
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay
Northcott, J. M., Bartha, G. T., Harris, J., Li, C., Navarro, F. C. P., Pyke, R. M., Hong, M., Zhang, Q., Ma, S., Chen, T. X., et al. (2024) · Oncotarget · doi:10.18632/oncotarget.28565 · Cited by 42
State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation
Pathak, P., Chan, G. H. J., Deming, D. A., & Chee, C. E. (2024) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_438466 · Cited by 43
Circulating tumor DNA – Current state of play and future perspectives
Rubis, G. D., Krishnan, S. R., & Bebawy, M. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.017 · Cited by 39
Contemporary Approach to the Diagnosis of Malignant Pleural Effusion
Kaul, V., McCracken, D. J., Rahman, N. M., & Epelbaum, O. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201902-189cme · Cited by 40
Kang, G., Chen, K., Yang, F., Chuai, S., Zhao, H., Zhang, K., Li, B., Zhang, Z., & Wang, J. (2019) · BMC Cancer · doi:10.1186/s12885-019-5751-9 · Cited by 41
Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy
Turano, M., Delrio, P., Rega, D., Cammarota, F., Polverino, A., Duraturo, F., Izzo, P., & Rosa, M. D. (2019) · Cancers · doi:10.3390/cancers11121932 · Cited by 40
Li, J., Jiang, W., Wei, J., Zhang, J., Cai, L., Luo, M., Wang, Z., Sun, W., Wang, S., Wang, C., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02449-y · Cited by 42
Liquid biopsy versus tumor biopsy for clinical-trial recruitment
Corcoran, R. B. (2020) · Nature Medicine · doi:10.1038/s41591-020-01169-6 · Cited by 42
DNA-Loaded Extracellular Vesicles in Liquid Biopsy: Tiny Players With Big Potential?
Garcı́a-Silva, S., Gallardo, M., & Peinado, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.622579 · Cited by 42
Network approach in liquidomics landscape
Santini, D., Botticelli, A., Galvano, A., Iuliani, M., Incorvaia, L., Gristina, V., Taffon, C., Foderaro, S., Paccagnella, E., Simonetti, S., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02743-9 · Cited by 37
Fu, Y., Yang, Z., Hu, Z., Yang, Z., Pan, Y., Chen, J., Wang, J., Hu, D., Zhou, Z., Xu, L., et al. (2022) · Hepatology International · doi:10.1007/s12072-022-10348-1 · Cited by 39
Liver transplantation in metastatic colorectal cancer: are we ready for it?
Ros, J., Salvà, F., Dopazo, C., López-Valbuena, D., Gonzalez, N. S., Baraibar, I., Charco, R., Tabernero, J. M., & Élez, E. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02213-1 · Cited by 40
Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer
Caban, M., & Małecka-Wojciesko, E. (2023) · Cancers · doi:10.3390/cancers15235577 · Cited by 46
Hsu, H., Lapke, N., Wang, C., Lin, P.-Y., You, J. F., Yeh, C. Y., Tsai, W., Hung, H., Chiang, S.-F., Chen, H., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1306 · Cited by 38
Čuperlović‐Culf, M., & Badhwar, A. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1674808 · Cited by 40
Circulating Tumor DNA Testing Opens New Perspectives in Melanoma Management
Sacco, A., Forgione, L., Carotenuto, M., Luca, A. D., Ascierto, P. A., Botti, G., & Normanno, N. (2020) · Cancers · doi:10.3390/cancers12102914 · Cited by 40
Metadata
- Authors
- Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.-L., Christie, M., Kosmider, S., Skinner, I., Wong, R., Steel, M., Tran, B., Desai, J., Jones, I., Haydon, A., Hayes, T., Price, T. J., Strausberg, R. L., Diaz, L. A., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., & Gibbs, P.
- Affiliations
- The University of Melbourne (AU)
- Howard Hughes Medical Institute (US)
- Johns Hopkins University (US)
- PapGene (United States) (US)
- The Royal Melbourne Hospital (AU)
- Western Health (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Eastern Health (AU)
- The Alfred Hospital (AU)
- Department of Medical Oncology, Warrnambool Hospital, Warrnambool, Victoria 3280, Australia.
- Department of Medical Oncology, Queen Elizabeth Hospital and University of Adelaide, Adelaide, South Australia 3174, Australia.
- Ludwig Cancer Research (US)
- Corresponding author
- Tie, Jeanne
- Wang, Yuxuan
- Vogelstein, Bert
- Gibbs, Peter
- ORCID
- Tie, Jeanne
- Wang, Yuxuan
- Tomasetti, Cristian
- Li, Lu
- Springer, Simeon
- Silliman, Natalie
- Tacey, Mark
- Wong, Hui-Li
- Christie, Michael
- Kosmider, Suzanne
- Skinner, Iain
- Wong, Rachel
- Steel, Malcolm
- Tran, Ben
- Desai, Jayesh
- Jones, Ian
- Haydon, Andrew
- Hayes, Theresa
- Diaz, Luis A.
- Papadopoulos, Nickolas
- Kinzler, Kenneth W.
- Vogelstein, Bert
- Gibbs, Peter
- Venue
- Science Translational Medicine
- Published
- 2016-07-06
- Volume
- 8
- Issue
- 346
- Pages
- 346ra92-346ra92
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC5346159
- OpenAlex
- W2460179076
- Cited by
- 1,492
- References
- 43
- Citations by year
- 2026: 119 · 2025: 131 · 2024: 130 · 2023: 181 · 2022: 173 · 2021: 197 · 2020: 173 · 2019: 146 · 2018: 134 · 2017: 90 · 2016: 14
- FWCI
- 53.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- Virginia and D.K. Ludwig Fund for Cancer Research
- Conrad N. Hilton Foundation
- Sol Goldman Sequencing Facility at Johns Hopkins
- NIH (CA57345, R37-CA43460, U01-CA152753, P30-CA006973)
- Victorian Cancer Agency
- Victorian Cancer Agency Clinical Research Fellowship
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- circulating tumor DNA, stage II colon cancer, minimal residual disease, tumor recurrence prediction, adjuvant chemotherapy, liquid biopsy, recurrence-free survival, plasma biomarkers, resected colon cancer
- MeSH terms
- Circulating Tumor DNA, Colonic Neoplasms, Humans, Neoplasm Recurrence, Local, Neoplasm Staging, Prospective Studies, Proportional Hazards Models, Neoplasm, Residual, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
